Close Window
Laurus Labs Aptuit Laurus Labs Click here if you do not want to see this message again
Bookmark Page
Get Adobe Flash player

This page requires Flash Player version 8.0.24 or higher.

Get In Touch
Contact Aptuit
Email
Email us at info@aptuit.com
Email
For general sales & enquiries
USA +1 855 506 6360
EUROPE +39 045 8219333
Email
Alternatively, contact one of our
facilities directly
Greenwich HQ +1 203 422 6600 Oxford +44 1235 433600
Glasgow +44 141 945 8400 Verona +39 045 8218111
Harrisonville +1 816 380 3121 Visakhapatnam +91 3061222
Hyderabad +91 40 39804333 West Lafayette +1 765 463 0112
Contact Aptuit Footer
Printer Friendly Text Only Page
A
A
A

Press Releases

Blue underline
Close
Forward to a Friend
Simply fill in the fields below and we will email your friend/colleague a link to this page:
Your friend/colleague's name:  
Your friend/colleague's email address:    
Your Name:  
Close
Solid State Chemistry Educational Survey
Solid State Chemistry plays a very important role in the development of a drug. This includes polymorphs, cocrystals, salts and amorphous materials as well as the analysis of an API and a drug formulation with regard to their solid-state chemistry properties.

Please help us to gauge the industry's interest in an educational Solid State Chemistry course by participating in the survey:
Solid State Chemistry Educational Survey - 10% Discount
Please click here to fill in the questionnaire and register for your 10% discount off any Aptuit hosted short courses.
Solid State Chemistry Educational Survey - Anonymous
Please click here to fill in the questionnaire
anonymously.
No thanks
To register for your 10% discount off any Aptuit hosted short course please fill in your details below:
Your first name:  
Your last name:  
Your company
name:  
Your email
address:    
Your contact
phone number:  
Your country:  
Simply check the most appropriate answer box for each question and click submit when you have finished:
Have you ever attended an SSCI short course?  
If yes, please rate your experience:
(from 1:Poor to 5:Outstanding)
If no, why not?
Would you be interested in a short course on Solid State Chemistry?  
What would be the ideal length of a course of this nature?
Would you be willing to pay for the educational course, if so up to how much?  
Would you be willing to travel to the course?
What level of knowledge should the course cover?
What do you normally look for when attending these types of events?
(check all that apply)




Solid State Chemistry plays a very important role in the development of a drug. This includes polymorphs, cocrystals, salts and amorphous materials as well as the analysis of an API and a drug formulation with regard to their solid-state chemistry properties.

Please provide any specific topics you would like to see covered in a course of this nature:  
Please provide the names of any specific speakers you would like to see present at the course, e.g. leading academics, representatives from government:  
Simply check the most appropriate answer box for each question and click submit when you have finished:
Have you ever attended an SSCI short course?  
If yes, please rate your experience:
(from 1:Poor to 5:Outstanding)
If no, why not?
Would you be interested in a short course on Solid State Chemistry?  
What would be the ideal length of a course of this nature?
Would you be willing to pay for the educational course, if so up to how much?  
Would you be willing to travel to the course?
What level of knowledge should the course cover?
What do you normally look for when attending these types of events?
(check all that apply)




Solid State Chemistry plays a very important role in the development of a drug. This includes polymorphs, cocrystals, salts and amorphous materials as well as the analysis of an API and a drug formulation with regard to their solid-state chemistry properties.

Please provide any specific topics you would like to see covered in a course of this nature:  
Please provide the names of any specific speakers you would like to see present at the course, e.g. leading academics, representatives from government:  
Solid State Chemistry Educational Survey


Thank you


Your comments are appreciated. If you have registered for your 10% discount, please claim this at the time of booking your Aptuit-hosted course.
Close

Aptuit names Dr Jan-Olav Henck as Chief Scientific Officer

10.06.2011

Greenwich, CT, October 1, 2011 – Timothy C. Tyson, Chairman and CEO of Aptuit, Inc., announces the appointment of Dr. Jan-Olav Henck as Chief Scientific Officer, effective October 1, 2011. Dr. Henck will report to Stuart E. Needleman, President, Aptuit Scientific Operations. Mr. Tyson commented that the establishment of the CSO reflects the company’s commitment to provide scientific expertise and strongly supports Aptuit’s focus to engineer a better drug development process through scientific excellence.

Mr. Tyson explained, “Science is at the forefront of our mission, and we firmly believe that having a CSO in place will enhance our overall service offering. The CSO will coordinate the scientific capabilities and efforts of our company, managing developments as well as partnerships for pharmaceutical research and development.

In speaking of his new role at Aptuit, Dr. Henck said, "I am pleased to be Aptuit’s CSO, and I’m looking forward to the work that lies ahead, leading an outstanding scientific team. Our dedication to our clients’ success, anticipating their needs and addressing specific challenges, is our foremost objective. It will be very exciting and rewarding to develop new Scientific Offerings that will allow our clients to bring safe drugs to patients faster. "

Jan-Olav Henck, a world renowned solid state chemist


Dr. Henck holds a doctorate in Physical Chemistry. After obtaining his Ph.D. he became an Alexander von Humboldt Foundation postdoctoral fellow (Feodor-Lynen-Programme) with Professor Joel Bernstein at the Ben-Gurion University of the Negev in Israel. In 1999, Dr. Henck joined Bayer HealthCare in Leverkusen, Germany, where he focused on solid-state Chemistry of drugs and its impact on pharmaceutical formulations. Dr. Henck moved to the United States in 2005 when he was appointed Research Director in Analytical Research at SSCI in West Lafayette, Indiana. In the following year, he advanced to Senior Director of SSCI, leading the Chemistry Group with a primary focus on polymorphism studies, cocrystal and salt screening, amorphous screens and computational studies of drug substances. Most recently, Dr. Henck was Site Director for what had become Aptuit’s SSCI Division. To date, Dr. Henck has 5 patents and has co-authored 21 publications. He is also an Adjunct Professor at Purdue University, Department of Industrial and Physical Pharmacy.

Mr. Needleman noted that Dr. Henck has "worked tirelessly to further expand the scientific knowledge of peers and Aptuit clients." He said, "Aptuit could not ask for a more qualified, accomplished and dedicated scientist than Jan-Olav, whose talents and background make him the ideal Chief Scientific Officer at our company. I am pleased to express my sincere congratulations to him on behalf of all of Aptuit’s team."

For more information, please contact Maria Garvey, Delfino Marketing at 914-747-1400 or maria@delfino.com.

Aptuit is a global pharmaceutical services company focusing on delivering contract development and manufacturing services and streamlining the drug development process for biotechnology and pharmaceutical innovators. Aptuit's employees deliver an integrated suite of product development services to more than 800 companies worldwide driven by a deep commitment to client service, quality and an unrivaled track record of scientific excellence. The company is partnered with Welsh, Carson, Anderson & Stowe, one of the world's leading private equity investors. For more information about Aptuit, visit www.aptuit.com

Aptuit: engineering a better drug development process through scientific excellence

Home| Contact| About Us| Resource Library| Legal| Privacy| Site Map
© 2012 Aptuit LLC All Rights Reserved.